A Modular Phase II, Single-arm, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of AZD0486 in Participants with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma | Azienda Ospedaliero - Universitaria SS. Antonio e Biagio e Cesare Arrigo - Alessandria

A Modular Phase II, Single-arm, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of AZD0486 in Participants with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Promotore: AstraZeneca

Acronimo: SOUNDTRACK-B (D7404C00001)

Struttura: Ematologia

Sperimentatore principale: Ladetto Marco

Stato arruolamento: In attesa di arruolamento

Linee di ricerca: Linfoma non Hodgkin